News
-
-
PRESS RELEASE
Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax prices highly oversubscribed $800M public offering of American Depositary Shares, with increased gross proceeds expected to support commercialization efforts and clinical development -
-
-
-
-
-
-
PRESS RELEASE
Abivax Announces Launch of Public Offering of American Depositary Shares
Abivax announces launch of public offering of American Depositary Shares for approximately $600 million to fund commercialization efforts and research expenses. Underwriters include Leerink Partners and Morgan Stanley -